Search Within

Harold Varmus

Formats
  1. Journal Article (78)
  2. Meeting Abstract (12)
  3. Book Section (2)
  4. Book Whole (2)
  5. Conference Paper (2)
Groups
  1. Department of Medicine (12)
  2. Department of Pathology and Laboratory Medicine (12)
  3. Solid Tumor Oncology Division (12)
  4. GSK Faculty (10)
  5. Thoracic Oncology (9)
  6. Human Oncology and Pathogenesis Program (8)

More Groups

People
  1. William Pao (14)
  2. Katerina Politi (12)
  3. Katrina Podsypanina (9)
  4. Mark Kris (9)
  5. Maureen Zakowski (9)
  6. Marc Ladanyi (7)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2016 (1)
  4. 2015 (2)
  5. 2013 (1)
  6. 2012 (1)

More Years

Publications
  1. Proceedings of the National Academy of Sciences of the United States of America (14)
  2. Science (11)
  3. Nature (6)
  4. Genes and Development (4)
  5. Nature Genetics (4)
  6. Journal of Clinical Oncology (3)

More Publications

Publishers
  1. National Academy of Sciences (14)
  2. Nature Publishing Group (12)
  3. American Association for the Advancement of Science (11)
  4. Public Library of Science (8)
  5. Biomed Central Ltd (6)
  6. American Society for Microbiology (5)

More Publishers

Results (96)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics
    Journal Article

    Fan, P. D.; Narzisi, G.; Jayaprakash, A. D.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Yu, H. A.; Jordan, E. J.; Paik, P. K.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2018)

    Fulltext@MSK | Save
  • YES1 amplification as a mechanism of acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKIs) identified by a transposon mutagenesis screen and clinical genomic testing
    Meeting Abstract

    Fan, P. D.; Narzisi, G.; Jayaprakash, A.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Jordan, E.; Wang, L.; Jungbluth, A. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma
    Journal Article

    McFadden, D. G.; Politi, K.; Bhutkar, A.; Chen, F. K.; Song, X.; Pirun, M.; Santiago, P. M.; Kim-Kiselak, C.; Platt, J. T.; Lee, E.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2016)

    Fulltext@MSK | Save
  • Loss of MIG6 accelerates initiation and progression of mutant epidermal growth factor receptor-driven lung adenocarcinoma
    Journal Article

    Maity, T. K.; Venugopalan, A.; Linnoila, I.; Cultraro, C. M.; Giannakou, A.; Nemati, R.; Zhang, X.; Webster, J. D.; Ritt, D.; Ghosal, S.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas
    Journal Article

    Song, X. L.; Fan, P. D.; Bantikassegn, A.; Guha, U.; Threadgill, D. W.; Varmus, H.; Politi, K.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • DOK2 inhibits EGFR-mutated lung adenocarcinoma
    Journal Article

    Berger, A. H.; Chen, M.; Morotti, A.; Janas, J. A.; Niki, M.; Bronson, R. T.; Taylor, B. S.; Ladanyi, M.; Van Aelst, L.; Politi, K.; more...
    PLoS ONE (2013)

    Fulltext@MSK | Save
  • Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1
    Journal Article

    Beverly, L. J.; Lockwood, W. W.; Shah, P. P.; Erdjument-Bromage, H.; Varmus, H.
    Proceedings of the National Academy of Sciences of the United States of America (2012)

    Fulltext@MSK | Save
  • Lung cancer bio-signatures in plasma based on the analysis of mouse models
    Meeting Abstract

    Taguchi, A.; Politi, K.; Pitteri, S. J.; Lockwood, W. W.; Faca, V. M.; Sage, J.; Kemp, C. J.; Varmus, H. E.; Hanash, S. M.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines
    Journal Article

    Somwar, R.; Erdjument-Bromage, H.; Larsson, E.; Shum, D.; Lockwood, W. W.; Yang, G.; Sander, C.; Ouerfelli, O.; Tempst, P. J.; Djaballah, H.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2011)

    Fulltext@MSK | Save
  • Receptor for hyaluronan-mediated motility isoform B promotes liver metastasis in a mouse model of multistep tumorigenesis and a tail vein assay for metastasis
    Journal Article

    Du, Y. C. N.; Chou, C. K.; Klimstra, D. S.; Varmus, H.
    Proceedings of the National Academy of Sciences of the United States of America (2011)

    Fulltext@MSK | Save